Characteristics of patients
| Characteristic . | No. of Cases . | % . |
|---|---|---|
| Age | ||
| No more than 60 years | 599 | 61 |
| Greater than 60 years | 388 | 39 |
| Sex | ||
| Female | 521 | 53 |
| Male | 466 | 47 |
| Ann Arbor stage | ||
| I-II | 250 | 25 |
| III-IV | 737 | 75 |
| No. of extranodal sites | ||
| 0-1 | 933 | 95 |
| At least 2 | 54 | 5 |
| BM involvement (959) | ||
| Absent | 461 | 48 |
| Present | 498 | 52 |
| Bulky disease (937) | ||
| Absent | 819 | 87 |
| Present | 118 | 13 |
| B Symptoms (980) | ||
| Absent | 832 | 85 |
| Present | 148 | 15 |
| Performance status (ECOG) (762) | ||
| 0-1 | 696 | 91 |
| At least 2 | 66 | 9 |
| Serum LDH level (838) | ||
| Normal | 696 | 83 |
| Above upper normal limit | 142 | 17 |
| Serum albumin level (676) | ||
| Greater than 3 g/dL | 646 | 96 |
| No more than 3 g/dL | 30 | 4 |
| Hemoglobin (823) | ||
| At least 12 g/dL (10 g/dL for w) | 757 | 92 |
| Less than 12 g/dL (10 g/dL for w) | 66 | 8 |
| ESR (772) | ||
| Less than 30 mm | 627 | 81 |
| At least 30 mm | 145 | 19 |
| International Prognostic Index (649) | ||
| Low risk | 369 | 57 |
| Low intermediate risk | 196 | 30 |
| High intermediate risk | 65 | 10 |
| High risk | 19 | 3 |
| Characteristic . | No. of Cases . | % . |
|---|---|---|
| Age | ||
| No more than 60 years | 599 | 61 |
| Greater than 60 years | 388 | 39 |
| Sex | ||
| Female | 521 | 53 |
| Male | 466 | 47 |
| Ann Arbor stage | ||
| I-II | 250 | 25 |
| III-IV | 737 | 75 |
| No. of extranodal sites | ||
| 0-1 | 933 | 95 |
| At least 2 | 54 | 5 |
| BM involvement (959) | ||
| Absent | 461 | 48 |
| Present | 498 | 52 |
| Bulky disease (937) | ||
| Absent | 819 | 87 |
| Present | 118 | 13 |
| B Symptoms (980) | ||
| Absent | 832 | 85 |
| Present | 148 | 15 |
| Performance status (ECOG) (762) | ||
| 0-1 | 696 | 91 |
| At least 2 | 66 | 9 |
| Serum LDH level (838) | ||
| Normal | 696 | 83 |
| Above upper normal limit | 142 | 17 |
| Serum albumin level (676) | ||
| Greater than 3 g/dL | 646 | 96 |
| No more than 3 g/dL | 30 | 4 |
| Hemoglobin (823) | ||
| At least 12 g/dL (10 g/dL for w) | 757 | 92 |
| Less than 12 g/dL (10 g/dL for w) | 66 | 8 |
| ESR (772) | ||
| Less than 30 mm | 627 | 81 |
| At least 30 mm | 145 | 19 |
| International Prognostic Index (649) | ||
| Low risk | 369 | 57 |
| Low intermediate risk | 196 | 30 |
| High intermediate risk | 65 | 10 |
| High risk | 19 | 3 |